A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Alkhalaf, Alaa

A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. [electronic resource] - Diabetes care Jul 2010 - 1598-601 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1935-5548

10.2337/dc09-2241 doi


Adjuvants, Immunologic--administration & dosage
Adult
Aged
Albuminuria--drug therapy
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Biomarkers--urine
Diabetes Mellitus, Type 2--drug therapy
Diabetic Nephropathies--drug therapy
Double-Blind Method
Drug Therapy, Combination
Female
Hepatitis A Virus Cellular Receptor 1
Humans
Kidney Tubules--drug effects
Male
Membrane Glycoproteins--urine
Middle Aged
Placebos
Receptors, Virus
Thiamine--administration & dosage